HMG
HMG (menotropin) is a gonadotropin preparation containing FSH and LH activity, studied and clinically used for fertility support and spermatogenesis-focused protocols.
Overview
HMG, also called menotropin, is a purified gonadotropin preparation containing both FSH and LH activity. It has FDA-approved reproductive uses and a legitimate clinical role in fertility treatment, including off-label male infertility protocols.
The source page focuses on the male-fertility use case, especially when HMG is paired with HCG to support spermatogenesis after hCG alone proves insufficient.
At a Glance
Protocol
Standard male-fertility protocol using a fixed dose three times weekly, typically alongside HCG.
Inject three times weekly on non-consecutive days. Because the source reconstitution yields a full 3.0 mL injection for 75 IU, this is one of the least convenient protocols in the batch and may require a larger syringe or split dosing at separate sites. Male-fertility use typically also assumes concurrent HCG.
Dose progression
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
How HMG works.
HMG supplies both FSH and LH activity, which is why it becomes valuable in male fertility settings where hCG alone is not enough to restore meaningful spermatogenesis. The FSH component supports Sertoli-cell function, while LH activity complements testicular steroidogenesis.
Clinical fertility literature supports improved sperm parameters and pregnancy rates when HMG is combined with HCG in appropriately selected patients. The timeline is long because spermatogenesis itself takes months, not weeks.
Effects
Observations from clinical or preclinical literature.
Caution
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
CoFactors
Life Factors
Complementary strategies for best outcomes.
Metrics
Day-to-day metrics worth tracking through the protocol.
- Semen-analysis parameters - primary outcome markers for this protocol
- Testosterone and estradiol response - useful where HCG is being run concurrently
- Testicular volume and fertility-related symptoms - monitor for trend changes
- Injection-site tolerance - especially important because volume is large
Labs
Baseline and periodic bloodwork to monitor systemic health during the protocol.
Supplies Calculator
Estimates assume the schedule defined for this peptide.
Dose Calculator
Dose Calculator
Preparation
Careful technique preserves potency. Solution should be clear — do not shake.
- Allow vial to reach room temperature for 15–20 minutes before reconstitution.
- Draw the chosen bacteriostatic water volume with a sterile syringe.
- Inject slowly down vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
- Use within 30 days; discard any unused solution after 30 days.
Technique
General subcutaneous guidance from clinical best-practice resources.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Storage
Notes
Notes
References
- International Journal of Reproductive BioMedicineRandomized trial of HMG plus HCG versus HCG alone in male infertility.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009564/
- Reproductive Medicine and BiologyReview of gonadotropin therapy for male infertility.https://pubmed.ncbi.nlm.nih.gov/30655575/
- Menopur product informationReconstitution, storage, and menotropin prescribing guidance.https://www.ferringfertility.com/menopur/
- ASRMGonadotropin use and fertility-treatment practice guidance.https://www.asrm.org/practice-guidance/practice-committee-documents/
- MedlinePlusGeneral subcutaneous injection instructions.https://medlineplus.gov/ency/patientinstructions/000430.htm